Thomas D. Zindrick, J.D.

Thomas D. Zindrick, J.D.

President and Chief Executive OfficeratGENELUX· In proxies 2022–2025

Pay in FY2025GENELUX stock +84.7% the same year

Thomas D. Zindrick, J.D. was paid $4.3M in FY2025 (Dec). GENELUX stock rose 84.7% that year.

Pay$100 in the stock at the end of FY24 → $185
Pay is from the Summary Compensation Table of each GENELUX proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GENELUXPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -64%
  2. DNX Biopharmaceuticals, Inc.Public company · 6 yr
    • Director2014 – 2020 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?